VT

Catheter Precision IncNYSE-MKT VTAK Stock Report

Last reporting period 30 Jun, 2024

Updated 21 Nov, 2024

Last price

Market cap $B

0.001

Micro

Exchange

XASE - Nyse MKT LLC

VTAK Stock Analysis

VT

Uncovered

Catheter Precision Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-33/100

Low score

Market cap $B

0.001

Dividend yield

Shares outstanding

0.9 B

Catheter Precision Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Fort Mill, South Carolina and currently employs 14 full-time employees. The company went IPO on 2018-09-27. Catheter Precision, Inc. is a medical device company. The company is engaged in providing new solutions to the market to improve the treatment of cardiac arrhythmias. The company is focused on developing technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. The company is also focused on developing and delivering electrophysiology products to provide patients, hospitals, and physicians with novel technologies and solutions to improve the lives of patients with cardiac arrhythmias. Its product is the VIVO System, which is an anacronym for View into Ventricular Onset System, which is a non-invasive imaging system that offers three-dimensional cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients. Its LockeT product is a suture retention device indicated for wound healing. Its product portfolio also includes the Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.

View Section: Eyestock Rating